Viewing nowHumetec Tablets 20 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hanmi Healthcare Co., Ltd.

MFDS item code 201100896 · Approved 2011.02.24 · Insurance code 649101960
Treatment of essential hypertension
Essential hypertension is high blood pressure that occurs without a specific cause; this medication lowers blood pressure, protecting heart and vascular health while helping to prevent complications. Regular intake contributes to stable blood pressure control. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be started at a low dose while their condition is monitored closely. <Elderly patients> No dosage adjustment is necessary when this drug is administered to patients aged 65 years or older. Although no overall differences in the efficacy or safety of this drug have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm or even death to the fetus or newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to any of the ingredients, pregnant or breastfeeding, undergoing renal dialysis, have severe liver disorders, have bile duct obstruction, or have genetic issues such as lactose intolerance. Be cautious if you have low blood volume or salt levels before taking this medication, as low blood pressure may occur; immediate appropriate actions must be taken if low blood pressure develops. Patients with impaired kidney function or those who have received a kidney transplant should regularly check potassium levels and kidney function indicators. Severe renal impairment is not advised for use of this medication. Patients with specific heart diseases or those at risk of hyperkalemia should regularly monitor serum potassium levels while on this medication. This medication may cause dizziness; caution is required when operating hazardous machinery or driving. If gastrointestinal symptoms such as chronic diarrhea or weight loss occur while taking this medication, consult a physician immediately. If symptoms of intestinal vascular edema appear, discontinue use and seek appropriate treatment. Caution is advised when taken with potassium-sparing diuretics or potassium supplements as it may dangerously elevate blood potassium levels, as well as with lithium or non-steroidal anti-inflammatory drugs. Taking this medication during pregnancy may lead to serious adverse effects in the fetus, such as low blood pressure, renal function impairment, and skull development issues; thus, it should be discontinued immediately upon confirmation of pregnancy. Breastfeeding may allow this medication to pass into breast milk, potentially causing adverse reactions in infants; therefore, it is recommended to either discontinue breastfeeding or stop taking the medication. The safety and efficacy of this medication in children have not been sufficiently established, so it should be administered cautiously to children. In elderly patients, the concentration of this medication may increase in the body, requiring caution during use. Overdosage may result in symptoms such as low blood pressure and palpitations, and appropriate treatment should be received if necessary. It has been reported that the risk of carcinogenicity or genotoxicity is low even with long-term administration of this medication; however, any adverse reactions should be reported to a healthcare professional immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 degree to 25 degrees Celsius. Proper storage facilitates the maintenance of the medication's effectiveness and prevents deterioration.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Hanmi Healthcare Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.